Drugs for Polyneuropathy (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):
(show top 50)
(show all 184)
# |
|
Name |
Status |
Phase |
Clinical Trials |
Cas Number |
PubChem Id |
1 |
|
Imipramine |
Approved |
Phase 4 |
|
50-49-7 |
3696 |
Synonyms:
10,11-Dihydro-N,N-dimethyl-5H-dibenz[b,F]azepine-5-propanamine
3-(5H-DIBENZO[b,F]azepin-5-yl)-N,N-dimethylpropan-1-amine
4,4'-Methylenebis(3-hydroxy-2-naphthoic acid)-3-(10,11-dihydro-5H-dibenzo(b,F)azepin-5-yl)-N,N-dimethyl-1-propanamine (1:2)
5-[3-(Dimethylamino)propyl]-10,11-dihydro-5H-dibenz[b,F]azepine
Antideprin
Berkomine
Censtim
Censtin
Chimoreptin
Declomipramine
Dimipressin
DPID
Dynaprin
Dyna-zina
Estraldine
Eupramin
Feinalmin
IM
Imavate
Imidobenzyle
imidobenzyle|Tofranil®
Imilanyle
Imipramin
Imipramina
Imipramine
Imipramine Hcl
Imipramine hydrochloride
Imipramine monohydrochloride
Imipramine pamoate
Imipraminum
Imiprin
Imizin
Imizine
Imizinum
Impramine
|
Intalpram
Iramil
Irmin
Janimine
Lofepramine
Melipramin
Melipramine
N-(gamma-Dimethylaminopropyl)iminodibenzyl
N-(g-Dimethylaminopropyl)iminodibenzyl
N-(Γ-dimethylaminopropyl)iminodibenzyl
Nelipramin
Norchlorimipramine
Norfranil
NSC-169866
ORG-2463
PRAMINE
Prazepine
PRESAMINE
Promiben
Pryleugan
Psychoforin
Sk-Pramine
Surmontil
Surplix
Teperine
Timolet
Tipramine
Tofranil
Tofranil base
Tofranil, Base
Tofraniln A
Tofranil-PM
Tofranil-PM (imipramine pamoate)
Trimipramine maleate
|
|
2 |
|
Citalopram |
Approved |
Phase 4 |
|
59729-32-7, 59729-33-8 |
2771 |
Synonyms:
[<sup>3</sup>H]-citalopram
Akarin
Bonitrile
Celapram
Celexa
Celexa®|Cipramil®|LU-10171B
Celius
Ciazil
Cilift
Cipram
CIPRAMIL
Ciprapine
Citabax
Citadur
Citalec
Citalopram
Citalopram hydrobromide
Citalopramum
Citalopramum [INN-Latin]
Citol
Citopam
Citox
|
Citrol
Cytalopram
Dalsan
Elopram
Escitalopram
Escitalopram oxalate
Humorup
Lexapro
LU 10-171-B
LU-10-171-B
Nitalapram
Oropram
PAXORAN
Pramcit
Recital
Seropram
Talam
Talohexal
Temperax
Vodelax
Zentius
Zetalo
|
|
3 |
|
Levetiracetam |
Approved |
Phase 4 |
|
102767-28-2 |
441341 5284583 |
Synonyms:
AGB-101
alpha Ethyl 2 oxo 1 pyrrolidineacetamide
alpha-Ethyl-2-oxo-1-pyrrolidineacetamide
DESITREND
e Keppra
ELEPSIA XR
Etiracetam
Etiracetam, R isomer
Etiracetam, R-isomer
Etiracetam, S isomer
Etiracetam, S-isomer
Keppra
KEPPRA XR
Keppra®|Spritam®|UCB L059|UCB-L 059
LEVETIRACETAM
Levetiracetam [INN]
LEVETIRACETAM IN SODIUM CHLORIDE
|
Levetiracetame
Levetiracetamum
Levetiracetamum [INN-Latin]
Levitiracetam
MATEVER
N03AX14
R-Isomer etiracetam
S-Isomer etiracetam
SPRITAM
UCB brand OF levetiracetam
Ucb L059
Ucb L060
UCB-22059
Ucb-L059
UcbL060
Ucb-L060
|
|
4 |
|
Acetylcholine |
Approved, Investigational |
Phase 4 |
|
51-84-3 |
187 |
Synonyms:
[2-(ACETYLOXY)ETHYL]TRIMETHYLAZANIUM
2-(Acetyloxy)-N,N,N-trimethylethanaminium
2-ACETOXYETHYL(TRIMETHYL)AMMONIUM
2-ACETYLOXYETHYL(TRIMETHYL)AMMONIUM
2-ACETYLOXYETHYL(TRIMETHYL)AZANIUM
Acetilcolina cusi
Acetyl choline ion
Acetylcholine
Acetylcholine bromide
Acetylcholine cation
Acetylcholine chloride
Acetylcholine fluoride
Acetylcholine hydroxide
Acetylcholine iodide
Acetylcholine L tartrate
Acetylcholine L-tartrate
Acetylcholine perchlorate
Acetylcholine picrate
Acetylcholine picrate (1:1)
Acetylcholine sulfate (1:1)
ACETYLCHOLINE, ACH
Acetylcholinium: acetyl-choline
|
ACh
ACh|E1001|O-acetylcholine
Alcon brand OF acetylcholine chloride
Azetylcholin
Bournonville brand OF acetylcholine chloride
Bromide, acetylcholine
Bromoacetylcholine
Chloroacetylcholine
Choline acetate
Choline acetate (ester)
Choline acetic acid
Ciba vision brand OF acetylcholine chloride
Cusi, acetilcolina
E1001
Fluoride, acetylcholine
Hydroxide, acetylcholine
Iodide, acetylcholine
Iolab brand OF acetylcholine chloride
L-Tartrate, acetylcholine
Miochol
O-Acetylcholine
Perchlorate, acetylcholine
|
|
5 |
|
Nortriptyline |
Approved |
Phase 4 |
|
72-69-5 |
4543 |
Synonyms:
10,11-Dihydro-N-methyl-5H-dibenzo[a,D]cycloheptene-delta(5,g)-propylamine
10,11-Dihydro-N-methyl-5H-dibenzo[a,D]cycloheptene-Delta(5,gamma)-propylamine
10,11-Dihydro-N-methyl-5H-dibenzo[a,D]cycloheptene-δ(5,g)-propylamine
10,11-Dihydro-N-methyl-5H-dibenzo[a,D]cycloheptene-δ(5,γ)-propylamine
10,11-dihydro-N-methyl-5H-dibenzo[a,d]cycloheptene-Δ5,γ-propylamine
3-(10,11-Dihydro-5H-dibenzo[a,D]cyclohepten-5-ylidene)-N-methyl-1-propanamine
Acetexa
Allegron
Altilev
Apo nortriptyline
Apo-nortriptyline
Apotex brand OF nortriptyline hydrochloride
Ateben
Avantyl
Aventyl
AVENTYL HCL
Aventyl®|nortriptyline hydrochloride|Pamelor®
Demethylamitriptylene
Demethylamitriptyline
Demethylamitryptyline
Desitriptilina
Desitriptyline
Desmethylamitriptylin
Desmethylamitriptyline
Dista brand OF nortriptyline hydrochloride
Gen nortriptyline
Gen-nortriptyline
Genpharm brand OF nortriptyline hydrochloride
Hydrochloride, nortriptyline
Lilly brand OF nortriptyline hydrochloride
Lumbeck
Lundbeck brand OF nortriptyline hydrochloride
Mallinckrodt brand OF nortriptyline hydrochloride
MOTIPRESS
|
MOTIVAL
NCI-169453
Noramitriptyline
Norfenazin
Noritren
Nortrilen
Nortriptylina
Nortriptyline
Nortriptyline Hcl
Nortriptyline hydrochloride
Nortriptylinum
Nortryptiline
Norzepine
Novo nortriptyline
Novo-nortriptyline
Novopharm brand OF nortriptyline hydrochloride
Nu nortriptyline
Nu pharm brand OF nortriptyline hydrochloride
Nu-nortriptyline
Nu-pharm brand OF nortriptyline hydrochloride
Pamelor
Paxtibi
Pharmascience brand OF nortriptyline hydrochloride
PMS Nortriptyline
PMS-Nortriptyline
Psychostyl
Ratio nortriptyline
Ratio-nortriptyline
Ratiopharm brand OF nortriptyline hydrochloride
Reig jofre brand OF nortriptyline hydrochloride
Sensaval
Sensival Ventyl
Sesaval
Vividyl
|
|
6 |
|
Mexiletine |
Approved, Investigational |
Phase 4 |
|
5370-01-4, 31828-71-4 |
4178 |
Synonyms:
(+-)-1-(2,6-Dimethylphenoxy)propan-2-amine
(±)-1-(2,6-dimethylphenoxy)propan-2-amine
(2Rs)-1-(2,6-Dimethylphenoxy)-2-aminopropane
1-(2',6'-Dimethylphenoxy)-2-aminopropane
1-(2,6-Dimethylphenoxy)-2-propanamine
1-Methyl-2-(2,6-xylyloxy)ethanamine
Boehringer ingelheim brand OF mexiletine hydrochloride
KO-1173
KO-1173 CL
KO-1173-CL
Mexiletene
Mexiletina
Mexiletina [INN-Spanish]
Mexiletine
|
Mexilétine
MEXILETINE HCL
Mexiletine hydrochloride
Mexiletinum
Mexiletinum [INN-Latin]
Mexilitine
Mexitil
MEXITIL P.L.
Mexitil PL
Mexitil®
Mexityl
Novo mexiletine
Novo-mexiletine
Novopharm brand OF mexiletine hydrochloride
|
|
7 |
|
Cilostazol |
Approved, Investigational |
Phase 4 |
|
73963-72-1 |
2754 |
Synonyms:
3,4-Dihydro-6-(4-(1-cyclohexyl-1H-tetrazol-5-yl)butoxy)-2(1H)-quinolinone
6-(4-(1-Cyclohexyl-1H-tetrazol-5-yl)butoxy)-3,4-dihydro-2(1H)-quinolinone
6-(4-(1-Cyclohexyl-1H-tetrazol-5-yl)butoxy)-3,4-dihydrocarbostyril
6-[4-(1-Cyclohexyl-1H-tetrazol-5-yl)-butoxy]-3,4-dihydro-1H-quinolin-2-one
CILOSTAZOL
Cilostazole
Cilostazolum
|
Cilostazolum [INN-Latin]
OPC-13013
OPC-13013|OPC-21|Pletal®
OPC-21
Pletaal
Pletal
|
|
8 |
|
Oxcarbazepine |
Approved |
Phase 4 |
|
28721-07-5 |
34312 |
Synonyms:
10,11-Dihydro-10-oxo-5H-dibenz(b,F)azepine-5-carboxamide
Desitin brand OF oxcarbazepine
GP-47680
KIN-493
Novartis brand OF oxcarbazepine
OCBZ
Oxcarbamazepine
Oxcarbazepina
|
Oxcarbazepine
Oxcarbazepinum
Oxtellar
OXTELLAR XR
SPN-804
Timox
TRI476
Trileptal
|
|
9 |
|
Ranolazine |
Approved, Investigational |
Phase 4 |
|
142387-99-3, 95635-55-5 |
56959 |
Synonyms:
(-)-Ranolazine
CVT-303
Dihydrochloride, ranolazine
HCL, Ranolazine
Hydrochloride, ranolazine
N-(2,6-DIMETHYLPHENYL)-2-[4-[2-HYDROXY-3-(2-METHOXYPHENOXY)PROPYL]PIPERAZIN-1-YL]ACETAMIDE
N-(2,6-Dimethylphenyl)-4-(2-hydroxy-3-(2-methoxyphenoxy)propyl)-1-piperazineacetamide
Ranexa
Ranolazina
|
Ranolazine
Ranolazine 2HCL
Ranolazine dihydrochloride
Ranolazine HCL
Ranolazine hydrochloride
Renolazine
RS-43285
RS-43285-003
|
|
10 |
|
Folic acid |
Approved, Nutraceutical, Vet_approved |
Phase 4 |
|
59-30-3 |
6037 |
Synonyms:
(2S)-2-[(4-{[(2-AMINO-4-OXO-1,4-DIHYDROPTERIDIN-6-YL)METHYL]AMINO}PHENYL)FORMAMIDO]PENTANEDIOIC ACID
(2S)-2-[[[4-[(2-AMINO-4-OXO-1H-PTERIDIN-6-YL)METHYLAMINO]PHENYL]-OXO-METHYL]AMINO]PENTANEDIOIC ACID
(2S)-2-[[4-[(2-AMINO-4-OXO-1H-PTERIDIN-6-YL)METHYLAMINO]BENZOYL]AMINO]GLUTARIC ACID
(2S)-2-[[4-[(2-AMINO-4-OXO-1H-PTERIDIN-6-YL)METHYLAMINO]BENZOYL]AMINO]PENTANEDIOIC ACID
(2S)-2-[[4-[(2-AMINO-4-OXO-1H-PTERIDIN-6-YL)METHYLAMINO]PHENYL]CARBONYLAMINO]PENTANEDIOIC ACID
[<sup>3</sup>H]-folic acid
Acide folique
ácido fólico
Acidum folicum
ACIFOLIC
Apo-Folic
B03BB01
b9, Vitamin
BIO SCIENCE
CYTOFOL
DOSFOLAT B ACTIV
FOLACID
FOLACIN
FOLATE
FOLBAL
FOLCIDIN
FOLDINE
FOLETTES
FOLIAMIN
FOLIC ACID
Folic acid, (D)-isomer
Folic acid, (DL)-isomer
Folic acid, calcium salt (1:1)
Folic acid, monopotassium salt
Folic acid, monosodium salt
Folic acid, potassium salt
Folic acid, sodium salt
FOLICARE
FOLICET
FOLIPAC
|
FOLSAEURE
FOLSAN
FOLSAURE
Folsäure
FOLSAV
FOLVITE
Folvron
INCAFOLIC
LEXPEC
LIVER LACTOBACILLUS CASEI FACTOR
MILLAFOL
N-(4-{[(2-AMINO-4-OXO-3,4-DIHYDROPTERIDIN-6-YL)METHYL]AMINO}BENZOYL)-L-GLUTAMIC ACID
N-[(4-{[(2-amino-4-oxo-1,4-dihydropteridin-6-yl)methyl]amino}phenyl)carbonyl]-L-glutamate
N-[(4-{[(2-AMINO-4-OXO-1,4-DIHYDROPTERIDIN-6-YL)METHYL]AMINO}PHENYL)CARBONYL]-L-GLUTAMIC ACID
N-[4-[[(2-AMINO-3,4-DIHYDRO-4-OXO-6-PTERIDINYL)METHYL]AMINO]BENZOYL]-L-GLUTAMIC ACID
NATUR FLOW
N-Pteroyl-L-glutamate
N-PTEROYL-L-GLUTAMIC ACID
NSC-3073
PGA
PRECONCEIVE
PTEGLU
PTEROYLGLUTAMATE
PTEROYLGLUTAMIC ACID
PTEROYL-L-GLUTAMATE
PTEROYL-L-GLUTAMIC ACID
PTEROYL-L-MONOGLUTAMATE
PTEROYL-L-MONOGLUTAMIC ACID
PTEROYLMONOGLUTAMIC ACID
ROCHE
Vitamin B9
VITAMIN BC
VITAMIN BE
VITAMIN M
|
|
11 |
|
Lipoic acid |
Approved, Investigational, Nutraceutical |
Phase 4 |
|
1200-22-2 |
864 6112 |
Synonyms:
(+)-a-Lipoate
(+)-a-Lipoic acid
(+)-alpha-Lipoate
(+)-alpha-Lipoic acid
(+)-α-lipoate
(+)-α-lipoic acid
(3R)-1,2-Dithiolane-3-pentanoic acid
(R)-(+)-1,2-Dithiolane-3-pentanoic acid
(R)-(+)-alpha-Lipoic acid
(R)-(+)-Lipoate
(R)-(+)-Lipoic acid
(R)-(+)-α-Lipoic acid
(R)-1,2-Dithiolane-3-pentanoate
(R)-1,2-Dithiolane-3-pentanoic acid
(R)-1,2-Dithiolane-3-valerate
(R)-1,2-Dithiolane-3-valeric acid
(R)-5-(1,2-Dithiolan-3-yl)pentanoicacid
(R)-6,8-Thioctate
(R)-6,8-Thioctic acid
(R)-alpha-Lipoic acid
(R)-Lipoate
(R)-Lipoic acid
(R)-α-Lipoic acid
1,2-Dithiolane-3-pentanoate
1,2-Dithiolane-3-pentanoic acid
1,2-Dithiolane-3R-pentanoate
1,2-Dithiolane-3R-pentanoic acid
1,2-Dithiolane-3-valerate
1,2-Dithiolane-3-valeric acid
5-(1,2-Dithiolan-3-yl)pentanoic acid
5-(1,2-Dithiolan-3-yl)valerate
5-(1,2-Dithiolan-3-yl)valeric acid
5-(3-DITHIOLANYL)PENTANOIC ACID
5-(DITHIOLAN-3-YL)PENTANOIC ACID
5-(Dithiolan-3-yl)valerate
5-(Dithiolan-3-yl)valeric acid
5-[3-(1,2-Dithiolanyl)]pentanoate
5-[3-(1,2-Dithiolanyl)]pentanoic acid
6,8-Thioctate
6,8-Thioctic acid
6,8-Thiotate
6,8-Thiotic acid
6-Thioctate
6-Thioctic acid
6-Thiotate
6-Thiotic acid
Acetate-replacing factor
Acetic acid-replacing factor
Acid, alpha-lipoic
ALA
a-Lipoate
a-Lipoic acid
a-Liponsaeure
Aliud brand OF thioctic acid
Alpha Lipogamma
alpha Lipoic acid
Alpha Lipon stada
alpha Liponaure heumann
Alpha Liponsaure sofotec
alpha Liponsaure von CT
Alpha Lippon al
alpha Vibolex
alpha-(+)-Lipoic acid
Alphaflam
alpha-Lipoate
AlphaLipogamma
Alpha-Lipogamma
alpha-Lipoic acid
AlphaLipon stada
Alpha-Lipon stada
alpha-Liponaure heumann
AlphaLiponaure heumann
alpha-Liponsaeure
ALPHA-LIPONSÄURE
AlphaLiponsaure sofotec
Alpha-Liponsaure sofotec
alpha-Liponsaure von CT
AlphaLiponsaure von CT
AlphaLippon al
Alpha-Lippon al
alpha-Vibolex
AlphaVibolex
Azulipont
Azupharma brand OF thioctic acid
Biletan
biomo Brand OF thioctic acid
Biomo lipon
Biomolipon
Biomo-lipon
CT Arzneimittel brand OF thioctic acid
CT-Arzneimittel brand OF thioctic acid
|
DL-a-Lipoate
DL-a-Lipoic acid
DL-alpha-Lipoate
DL-alpha-Lipoic acid
DL-Thioctate
DL-Thioctic acid
DL-Α-lipoate
DL-Α-lipoic acid
D-thioctic acid
Duralipon
Espa lipon
Espalipon
Espa-lipon
Esparma brand OF thioctic acid
Fenint
Generosan brand OF thioctic acid
Heumann brand OF thioctic acid
Hexal brand OF thioctic acid
Illa brand OF thioctic acid
Illa brand OF thioctic acid tromethamine
Injekt, thiogamma
Juta brand OF thioctic acid
Juthiac
Lichtenstein brand OF thioctic acid
Lipoate
Lipoic acid
LIPOIC ACID, ALPHA
Liponate
Liponic acid
Liponsaure ratiopharm
Liponsaureratiopharm
Liponsaure-ratiopharm
Merck dura brand OF thioctic acid
MTW Alphaliponsaure
MTW Brand OF thioctic acid
MTWAlphaliponsaure
MTW-Alphaliponsaure
Neurium
NSC-628502
NSC-90788
Pharmacia brand OF thioctic acid
Pleomix Alpha
Pleomix Alpha N
PleomixAlpha
Pleomix-Alpha
PleomixAlpha N
Pleomix-Alpha N
Q Pharm brand OF thioctic acid
Q-Pharm brand OF thioctic acid
R-(+)-Lipoate
R-(+)-Lipoic acid
R-(+)-thioctic acid
R-alpha-lipoic acid
Ratiopharm brand OF thioctic acid
RLA
R-LA
Rosen brand OF thioctic acid
Sofotec brand OF thioctic acid
Stadapharm brand OF thioctic acid
Thioctacid
Thioctacide T
Thioctansaeure
THIOCTANSÄURE
Thioctate
Thioctate D-form
Thioctic acid
Thioctic acid D-form
THIOCTIC ACID DL-FORM
Thioctsaeure
THIOCTSÄURE
Thiogamma injekt
Thiogamma oral
Thioktsaeure
THIOKTSÄURE
Thiotomin
TIOCTIC ACID
Tromlipon
Trommsdorgg brand OF thioctic acid
Verla brand OF thioctic acid
Verla lipon
Verla-lipon
VerlaLipon
Viatris brand OF thioctic acid
Viatris brand OF thioctic acid tromethamine
Worwag brand OF thioctic acid
Worwag brand OF thioctic acid meglumine
α-(+)-Lipoic acid
Α-lipoate
Α-lipoic acid
Α-liponsaeure
|
|
12 |
|
Dexetimide |
Withdrawn |
Phase 4 |
|
21888-98-2 |
30843 |
Synonyms:
(+)-BENZETIMIDE
(+)-benzetimide|R 16470|Tremblex®
Dexetimida
DEXETIMIDE
|
Dexetimidum
R 16470
R-16470 [AS HYDROCHLORIDE]
TREMBLEX
|
|
13 |
|
Folate |
|
Phase 4 |
|
|
|
14 |
|
Vitamins |
|
Phase 4 |
|
|
|
15 |
|
Vitamin B9 |
|
Phase 4 |
|
|
|
16 |
|
Trace Elements |
|
Phase 4 |
|
|
|
17 |
|
Vasodilator Agents |
|
Phase 4 |
|
|
|
18 |
|
Vitamin B Complex |
|
Phase 4 |
|
|
|
19 |
|
Micronutrients |
|
Phase 4 |
|
|
|
20 |
|
Anti-Arrhythmia Agents |
|
Phase 4 |
|
|
|
21 |
|
Alpha-lipoic Acid |
|
Phase 4 |
|
|
|
22 |
|
Serotonin Uptake Inhibitors |
|
Phase 4 |
|
|
|
23 |
|
Nootropic Agents |
|
Phase 4 |
|
|
|
24 |
|
abobotulinumtoxinA |
|
Phase 4 |
|
|
|
Synonyms:
ABOBOTULINUMTOXINA
BONT/A
BONTOXILYSIN A
BOTOX
BOTULINUM TOXIN TYPE A
|
BOTULINUM TOXINS, TYPE A
BOTULOTOXIN A
BTX-A
ONABOTULINUMTOXINA
|
|
25 |
|
Botulinum Toxins, Type A |
|
Phase 4 |
|
|
|
26 |
|
Botulinum Toxins |
|
Phase 4 |
|
|
|
27 |
|
Cholinergic Agents |
|
Phase 4 |
|
|
|
28 |
|
Antidepressive Agents, Tricyclic |
|
Phase 4 |
|
|
|
29 |
|
Respiratory System Agents |
|
Phase 4 |
|
|
|
30 |
|
Fibrinolytic Agents |
|
Phase 4 |
|
|
|
31 |
|
Bronchodilator Agents |
|
Phase 4 |
|
|
|
32 |
|
Anti-Asthmatic Agents |
|
Phase 4 |
|
|
|
33 |
|
Neuroprotective Agents |
|
Phase 4 |
|
|
|
34 |
|
Phosphodiesterase Inhibitors |
|
Phase 4 |
|
|
|
35 |
|
Phosphodiesterase 3 Inhibitors |
|
Phase 4 |
|
|
|
36 |
|
Platelet Aggregation Inhibitors |
|
Phase 4 |
|
|
|
37 |
|
Immunoglobulin G |
|
Phase 4 |
|
|
|
38 |
|
Sodium Channel Blockers |
|
Phase 4 |
|
|
|
39 |
|
Diuretics, Potassium Sparing |
|
Phase 4 |
|
|
|
40 |
|
Methyltestosterone |
Approved |
Phase 2, Phase 3 |
|
58-18-4 |
6010 |
Synonyms:
17 alpha Methyltestosterone
17 beta Hydroxy 17 methyl 4 androsten 3 one
17 beta Methyltestosterone
17 beta-Hydroxy-17-methyl-4-androsten-3-one
17 beta-Methyltestosterone
17 Epimethyltestosterone
17(a)-Methyl-delta(4)-androsten-17(b)-ol-3-one
17(a)-Methyl-δ(4)-androsten-17(b)-ol-3-one
17(alpha)-Methyl-Delta(4)-androsten-17(beta)-ol-3-one
17(Α)-methyl-δ(4)-androsten-17(β)-ol-3-one
17alpha Methyl testosterone
17alpha Methyltestosterone
17alpha-Methyl-3-oxo-4-androsten-17beta-ol
17alpha-Methyl-Delta(4)-androsten-17beta-ol-3-one
17alpha-Methyl-delta-androsten-17beta-ol-3-one
17alpha-Methyltestosterone
17alpha-Methyl-testosterone
17-alpha-Methyltestosterone
17a-Methyl-3-oxo-4-androsten-17b-ol
17a-Methyl-delta(4)-androsten-17b-ol-3-one
17a-Methyltestosterone
17a-Methyl-δ(4)-androsten-17b-ol-3-one
17beta Hydroxy 17 methyl 4 androsten 3 one
17beta Methyltestosterone
17beta-Hydroxy-17-methyl-4-androsten-3-one
17beta-Hydroxy-17-methylandrost-4-en-3-one
17-beta-Hydroxy-17-methylandrost-4-en-3-one
17beta-Methyltestosterone
17b-Hydroxy-17-methylandrost-4-en-3-one
17-b-Hydroxy-17-methylandrost-4-en-3-one
17-Epimethyltestosterone
17-Methyltestosterone
17Α-methyl-3-oxo-4-androsten-17β-ol
17Α-methyltestosterone
17Α-methyl-δ(4)-androsten-17β-ol-3-one
17Α-METHYL-Δ4-ANDROSTEN-17Β-OL-3-ONE
17Î’-hydroxy-17-methylandrost-4-en-3-one
17-Î’-hydroxy-17-methylandrost-4-en-3-one
4-Androstene-17alpha-methyl-17beta-ol-3-one
4-Androstene-17a-methyl-17b-ol-3-one
|
4-Androstene-17α-methyl-17β-ol-3-one
Android
Android (methyltestoterone)
Android 10
Android 25
Android 5
Android-10
Android-25
Android-5
CDB-110
Global pharmaceutical brand OF methyltestosterone
ICN brand 1 OF methyltestosterone
ICN brand 2 OF methyltestosterone
L 589.372
L-589.372
L-589372
Mesteron
Mesterone
Metandren
Methitest
Methyltestosterone
METHYLTESTOSTERONE CIII
Methyltestosteronum
Metiltestosterona
NSC-139965
NSC-9701
Oreton
ORETON METHYL
PERANDREN
PLEX HORMONE
POTENSAN FTE
RU 24400
RU-24400
Schering brand OF methyltestosterone
Star brand OF methyltestosterone
Testoviron
TESTOVIS
Testred
U-2842
Virilon
|
|
41 |
|
Testosterone undecanoate |
Approved, Investigational |
Phase 2, Phase 3 |
|
5949-44-0 |
21873174 65157 |
Synonyms:
2,15-Dimethyl-5-oxotetracyclo[8.7.0.0,.0,]heptadec-6-en-14-yl undecanoic acid
ANDRIOL
AVEED
JATENZO
MK-3033
NEBIDO
ORG-538
RESTANDOL
|
RESTANDOL TESTOCAP
Testosterone undecanoate
Testosterone undecanoic acid
Testosterone undeconate
Testosterone undecylate
TSX-011
UNDESTOR
|
|
42 |
|
Testosterone enanthate |
Approved |
Phase 2, Phase 3 |
|
315-37-7 |
9416 |
Synonyms:
17-((1-Oxoheptyl)oxy)androst-4-en-3-one
17beta-Enanthoxyandrost-4-en-3-one
17beta-Hydroxyandrost-4-en-3-one enanthate
17beta-Hydroxyandrost-4-en-3-one heptanoate
17beta-Hydroxyandrost-4-en-3-one heptanoic acid
17b-Hydroxyandrost-4-en-3-one heptanoate
17b-Hydroxyandrost-4-en-3-one heptanoic acid
17-Hydroxyandrost-4-en-3-one, 17-heptanoate
17-Hydroxyandrost-4-en-3-one, 17-heptanoic acid
17Î’-hydroxyandrost-4-en-3-one heptanoate
17Î’-hydroxyandrost-4-en-3-one heptanoic acid
4-Androsten-17beta-ol-3-one 17-enanthate
4-Androsten-3-one 17beta-enanthate
Androgyn l.a.
Andropository
Androtardyl
Atlatest
BTG Brand OF testosterone enanthate
DEA no. 4000
Delatest
Delatestryl
DePatestrye
depo-testro Med
Ditate
Durathate
eifelfango Brand OF testosterone enanthate
Everone
Exten test
Jenapharm brand OF testosterone enanthate
Malogen l.a.
Malogen l.a.200
NSC-17591
Orquisteron-e
Pasadena brand OF testosterone enanthate
Primoteston depot
|
Primotestone
reposo TMD
Roberts brand OF testosterone enanthate
Rotexmedica brand OF testosterone enanthate
Rugby brand OF testosterone enanthate
Schering brand OF testosterone enanthate
Testanthate
Testate
Testenate
Testinon
Testoenant
Testonenant
Testosteron depot-rotexmedica
Testosteron-depot eifelfango
Testosteron-depot jenapharm
Testosterone 17beta-heptanoate
Testosterone 17beta-heptanoic acid
Testosterone 17-enanthate
Testosterone 17-enanthic acid
Testosterone enantate
Testosterone enanthate
TESTOSTERONE ENANTHATE CIII
Testosterone enanthic acid
Testosterone heptanoate
Testosterone heptanoic acid
Testosterone heptoate
Testosterone heptoic acid
Testosterone heptylate
Testosterone oenanthate
Testostroval
Testrin p.a.
Theramed brand OF testosterone enanthate
Theramex
XYOSTED (AUTOINJECTOR)
|
|
43 |
|
Testosterone |
Approved, Investigational |
Phase 2, Phase 3 |
|
58-22-0 |
5408 6013 |
Synonyms:
(+-)-8-ISO-TESTOSTERONE
(+-)-RETROTESTOSTERONE
(+)-TESTOSTERONE
(+-)-TESTOSTERONE
(17B)-17-HYDROXY-ANDROST-4-EN-3-ONE
(1S,2R,10R,11S,14S,15S)-14-HYDROXY-2,15-DIMETHYLTETRACYCLO[8.7.0.0^{2,7}.0^{11,15}]HEPTADEC-6-EN-5-ONE
13-ISO-TESTOSTERONE
17 beta Hydroxy 4 androsten 3 one
17 beta Hydroxy 8 alpha 4 androsten 3 one
17A-HYDROXY-(13A)-ANDROST-4-EN-3-ONE
17A-HYDROXY-13A-ANDROST-4-EN-3-ONE
17A-HYDROXY-14B-ANDROST-4-EN-3-ONE
17A-HYDROXY-ANDROST-4-EN-3-ONE
17-beta-Hydroxy-4-androsten-3-one
17BETA-HYDROXY-4-ANDROSTEN-3-ONE
17-beta-Hydroxy-8 alpha-4-androsten-3-one
17B-HYDROXY-(10A)-ANDROST-4-EN-3-ONE
17B-HYDROXY-(13A)-ANDROST-4-EN-3-ONE
17B-HYDROXY-(8A)-ANDROST-4-EN-3-ONE
17B-HYDROXY-(8A,10A)-ANDROST-4-EN-3-ONE
17B-HYDROXY-(9B)-ANDROST-4-EN-3-ONE
17B-HYDROXY-(9B,10A)-ANDROST-4-EN-3-ONE
17B-HYDROXY-13A-ANDROST-4-EN-3-ONE
17b-Hydroxy-4-androsten-3-one
17B-HYDROXY-8A-ANDROST-4-EN-3-ONE
17B-HYDROXY-ANDROST-4-EN-3-ON
17B-HYDROXYANDROST-4-EN-3-ONE
17B-HYDROXY-ANDROST-4-EN-3-ONE
17B-HYDROXYANDROST-4-ENE-3-ONE
17B-HYDROXY-D4-ANDROSTEN-3-ONE
17B-TESTOSTERONE
17-HYDROXY-10,13-DIMETHYL-1,2,6,7,8,9,10,11,12,13,14,15,16,17-TETRADECAHYDRO-CYCLOPENTA[A]PHENANTHREN-3-ONE
17-HYDROXY-ANDROST-4-EN-3-ONE
17-HYDROXY-D4-ANDROSTEN-3-ONE
17Î’-hydroxy-4-androsten-3-one
4-ANDROSTEN-17BETA-OL-3-ONE
4-Androsten-17b-ol-3-one
4-ANDROSTEN-17Î’-OL-3-ONE
4-ANDROSTEN-3-ONE-17B-OL
8 Isotestosterone
8-Isotestosterone
8-ISO-TESTOSTERONE
9B,10A-TESTOSTERONE
9B-TESTOSTERONE
Andriol
Andro
Andro 100
Andro L.A. 200
ANDRODERM
Androderm®|Delatestryl®
ANDROGEL
ANDROGEL 1%
Android 10
Android 25
Android 5
Androlin
Andronaq
Andronate 100
Andronate 200
ANDROPATCH
Andropository 200
Androsorb
ANDROST-4-EN-17B-OL-3-ONE
ANDROST-4-ENE-17B-OL-3-ONE
Androtop
Andrusol
Andryl 200
AstraZeneca brand OF testosterone
Auxilium pharmaceuticals inc. brand OF testosterone
AXIRON
Bartor brand OF testosterone
Beta Testosterone
Bio-T-Gel
CDB 111C
CEPA brand OF testosterone
Cristerona T
Cristerone T
D4-ANDROSTEN-17B-OL-3-ONE
Dea No. 4000
Delatest
DELATESTRYL
Depotest
Depo-Testosterone
Depo-Testosterone Cypionate
Dr. kade brand OF testosterone
Epitestosteron
Everone 200
Faulding brand OF testosterone
Ferring brand OF testosterone
FORTESTA
Geno-cristaux gremy
GlaxoSmithKline brand OF testosterone
Hauck brand OF testosterone
Histerone
Homosteron
Homosterone
INTRINSA
Libigel
LUMITESTOSTERON
|
Malerone
Malestrone
Malogen in Oil
Malogen, Aquaspension Injection
MERTESTATE
Metandren
Methyltestosterone
NATESTO
Neo-Hombreol F
Neotestis
Neo-Testis
NSC-9700
Oreton
Oreton F
Oreton Methyl
Oreton-F
Orquisteron
Ortho brand OF testosterone
Paladin brand OF testosterone
Pasadena brand OF testosterone
Perandren
Percutacrine androgenique
Primotest
Primoteston
RAC-17B-HYDROXY-(13A)ANDROST-4-EN-3-ONE
RAC-17B-HYDROXY-(8A)-ANDROST-4-EN-3-ONE
RAC-17B-HYDROXY-(9B,10A)ANDROST-4-EN-3-ONE
RAC-17B-HYDROXY-ANDROST-4-EN-3-ONE
Relibra
RETROTESTOSTERONE
Scheinpharm Testone-Cyp
Schering brand OF testosterone
SmithKline beecham brand OF testosterone
Solvay brand OF testosterone
Sterotate
STRIANT
STRIANT SR
Sustanon
Sustanone
Sustason 250
Synandrol F
T-Cypionate
TES
Teslen
Testamone 100
Testandrone
Testaqua
Testiculosterone
TESTIM
TESTIM 1%
Testobase
TESTODERM
TESTODERM TTS
TESTOGEL
Testoject-50
Testolent
Testolin
TESTOPATCH
TESTOPEL
Testopel Pellets
Testopropon
TESTORAL
Testosteroid
TESTOSTERON
TESTOSTERONA
Testosterona [INN-Spanish]
TESTOSTERONE
TESTOSTÉRONE
TESTOSTERONE CIII
Testosterone Cypionate
Testosterone Enanthate
Testosterone Hydrate
Testosterone sulfate
TESTOSTERONUM
Testosteronum [INN-Latin]
Testostosterone
Testoviron
Testoviron schering
Testoviron T
Testred
Testred Cypionate 200
Testrin-P.A
Testro aq
TESTRONE
Testryl
TOSTRAN
Tostrelle
Tostrex
Trans-Testosterone
Ulmer brand OF testosterone
Unimed brand OF testosterone
Viatrel
Virilon
Virilon IM
Virormone
VIROSTERONE
VOGELXO
Watson brand OF testosterone
|
|
44 |
|
Rituximab |
Approved |
Phase 3 |
|
174722-31-7 |
|
Synonyms:
ABP-798
ANTICD20
CT-P10
HS006
HS-006
HS-006 (RITUXIMAB BIOSIMILAR)
HSDB 7455|IDEC-C2B8|MabThera®|Rituxan®
IDEC-102
IDEC-C2B8
IG GAMMA-1 CHAIN C REGION
Ig gamma-2A chain C region, membrane-bound form
MABTHERA
MABTHERA RITUXAN
|
R-105 IDEC-102
radiolabeled murine anti-CD20
RG-105
RHCACD20MA
RITUXAN
RITUXIMAB
rituximab-abbs
rituximab-arrx
rituximab-pvvr
SAIT101
SAIT-101
Zevalin
|
|
45 |
|
Gabapentin |
Approved, Investigational |
Phase 3 |
|
60142-96-3 |
3446 |
Synonyms:
1-(Aminomethyl)cyclohexaneacetate
1-(Aminomethyl)cyclohexaneacetic acid
2-[1-(AMINOMETHYL)CYCLOHEXYL]ACETIC ACID
Aclonium
Apo gabapentin
Apo-gabapentin
ApoGabapentin
CI 945
CI 945|Go 3450|GOE 2450|GOE 3450|Neurontin®
CI-945
Convalis
DM-1796
GABAPENTIN
GABAPENTIN GR
Gabapentin hexal
Gabapentin ratiopharm
Gabapentin stada
Gabapentina
Gabapentine
|
Gabapentine [INN-French]
Gabapentino
Gabapentino [INN-Spanish]
Gabapentino [Spanish]
Gabapentin-ratiopharm
Gabapentinum
Gabapentinum [INN-Latin]
Gabapetin
GO 3450
GOE 2450
GOE 3450
GOE-3450
Gralise
Neurontin
Novo gabapentin
Novo-gabapentin
NovoGabapentin
Novo-gabapentine
PMS-Gabapentin
|
|
46 |
|
Mecobalamin |
Approved, Investigational |
Phase 3 |
|
13422-55-4 |
|
Synonyms:
ASIMIL B-12
B-MAX
CO-METHYLCOBALAMIN
MeCbl
Mecobalamin
Mecobalamina
|
Mecobalaminum
Methyl vitamin B12
Methyl(III)cobalamin
Methylcob(III)alamin
Methylcobalamin
|
|
47 |
|
Oxybutynin |
Approved, Investigational |
Phase 3 |
|
5633-20-5 |
4634 |
Synonyms:
4-(diethylamino)-2-Butynyl alpha-phenylcyclohexaneglycolate ester
4-(diethylamino)-2-Butynyl alpha-phenylcyclohexaneglycolic acid ester
4-(diethylamino)-2-Butynyl a-phenylcyclohexaneglycolate ester
4-(diethylamino)-2-Butynyl a-phenylcyclohexaneglycolic acid ester
4-(diethylamino)-2-Butynyl α-phenylcyclohexaneglycolate ester
4-(diethylamino)-2-Butynyl α-phenylcyclohexaneglycolic acid ester
4-(diethylamino)-2-Butynyl-alpha-cyclohexyl-alpha-hydroxybenzeneacetate
4-(diethylamino)-2-Butynyl-alpha-phenylcyclohexaneglycolate
4-diethylamino-2-Butinyl a-cyclohexylmandelat
4-diethylamino-2-Butinyl alpha-cyclohexylmandelat
4-diethylamino-2-Butinyl α-cyclohexylmandelat
4-diethylamino-2-Butynyl alpha-phenylcyclohexaneglycolate
4-diethylamino-2-Butynyl alpha-phenylcyclohexaneglycolic acid
4-diethylamino-2-Butynyl a-phenylcyclohexaneglycolate
4-diethylamino-2-Butynyl a-phenylcyclohexaneglycolic acid
4-diethylamino-2-Butynyl α-phenylcyclohexaneglycolate
4-diethylamino-2-Butynyl α-phenylcyclohexaneglycolic acid
Anturol
apo-Oxybutynin
Benzeneacetate, a-cyclohexyl-a-hydroxy-, 4-(diethylamino)-2-butynyl ester
Benzeneacetate, alpha-cyclohexyl-alpha-hydroxy-, 4-(diethylamino)-2-butynyl ester
Benzeneacetate, α-cyclohexyl-α-hydroxy-, 4-(diethylamino)-2-butynyl ester
Benzeneacetic acid, a-cyclohexyl-a-hydroxy-, 4-(diethylamino)-2-butynyl ester
Benzeneacetic acid, alpha-cyclohexyl-alpha-hydroxy-, 4-(diethylamino)-2-butynyl ester
Benzeneacetic acid, α-cyclohexyl-α-hydroxy-, 4-(diethylamino)-2-butynyl ester
Contimin
CONTIMIN 2.5
CONTIMIN 5
Cyclohexaneglycolate, alpha-phenyl-, 4-(diethylamino)-2-butynyl ester
Cyclohexaneglycolate, a-phenyl-, 4-(diethylamino)-2-butynyl ester
Cyclohexaneglycolate, α-phenyl-, 4-(diethylamino)-2-butynyl ester
Cyclohexaneglycolic acid, alpha-phenyl-, 4-(diethylamino)-2-butynyl ester
Cyclohexaneglycolic acid, a-phenyl-, 4-(diethylamino)-2-butynyl ester
Cyclohexaneglycolic acid, α-phenyl-, 4-(diethylamino)-2-butynyl ester
Cystonorm
Cystrin
Cystrin®|Ditropan®|oxybutynin chloride
Ditropan
DITROPAN XL
Dresplan
Dridase
Driptane
|
Gelnique
Gen-oxybutynin
Kentera
LYRINEL XL
novo-Oxybutynin
Nu-oxybutyn
Oxibutinina
Oxibutyninum
Oxyb abz
Oxybugamma
Oxybutin holsten
Oxybutinin
Oxybuton
OXYBUTYNIN
Oxybutynin al
Oxybutynin azu
Oxybutynin base
Oxybutynin chloride
Oxybutynin heumann
Oxybutynin hexal
Oxybutynin hydrochloride
Oxybutynin stada
Oxybutynin topical gel
Oxybutynin von CT
Oxybutynine
Oxybutynin-puren
Oxybutynin-ratiopharm
Oxybutyninum
Oxymedin
Oxytrol
OXYTROL FOR WOMEN
PMS-Oxybutynin
Pollakisu
PROMICTULINE
Renamel
Ryol
Spasmex oxybutynin
Spasyt
Tavor
Transdermal patch
URIMIN
Zatur
|
|
48 |
|
Diflunisal |
Approved, Investigational |
Phase 2, Phase 3 |
|
22494-42-4 |
3059 |
Synonyms:
2-(Hydroxy)-5-(2,4-difluorophenyl)benzoate
2-(Hydroxy)-5-(2,4-difluorophenyl)benzoic acid
2',4'-Difluoro-4-hydroxy-3-biphenylcarboxylate
2',4'-Difluoro-4-hydroxy-3-biphenylcarboxylic acid
5-(2,4-Difluorophenyl)salicylate
5-(2,4-Difluorophenyl)salicylic acid
Apo diflunisal
Apo-diflunisal
ApoDiflunisal
Apotex brand OF diflunisal
Cahill may roberts brand OF diflunisal
DIFLUNISAL
Diflunisal novopharm brand
DIFLUNISALUM
Dolobid
DOLOBID 500
|
Dolobid®
Dolobis
Dolocid
Frosst sa brand OF diflunisal
Merck brand OF diflunisal
Merck sharp and dohme brand OF diflunisal
Novo diflunisal
Novo-diflunisal
NovoDiflunisal
Novopharm brand OF diflunisal
Nu diflunisal
Nu pharm brand OF diflunisal
Nu-diflunisal
NuDiflunisal
Nu-pharm brand OF diflunisal
|
|
49 |
|
Oxaliplatin |
Approved, Investigational |
Phase 3 |
|
61825-94-3 |
43805 11947679 6857599 |
Synonyms:
ACT 078
ACT-078
DACPLAT
Diaminocyclohexane Oxalatoplatinum
Eloxatin
Eloxatine
Elplat
Foloxatine
JM-83
L-OHP
L-OHP CPD
MBP-426 (LIPOSOMAL OXALIPLATIN)
NSC-266046
Oxalatoplatin
|
Oxalatoplatinum
Oxaliplatin
Oxaliplatin [Usan:Inn:Ban]
oxaliplatine
oxaliplatino
Oxaliplatino [Spanish]
oxaliplatinum
Oxaliplatinum [Latin]
Oxaloplatine [French]
Oxaloplatino [Spanish]
RP-54780
SR-96669
Transplatin
|
|
50 |
|
Phenytoin |
Approved, Vet_approved |
Phase 2, Phase 3 |
|
57-41-0 |
1775 |
Synonyms:
5,5-Diphenylhydantoin
5,5-Diphenylimidazolidine-2,4-dione
5,5-Diphenyl-imidazolidine-2,4-dione
5,5-Diphenyltetrahydro-1H-2,4-imidazoledione
5,5-Dwufenylohydantoina
Aleviatin
Antisacer
Auranile
Causoin
Citrullamon
Citrulliamon
Comital
Comitoina
Convul
Danten
Dantinal
Dantoinal
Dantoinal klinos
Dantoine
Denyl
Didan TDC 250
Difenilhidantoina
Difenilhidantoina [Spanish]
Difenin
Difetoin
Difhydan
Dihycon
Dihydan
Di-Hydan
Dihydantoin
DILABID
Di-Lan
DILANTIN
Dilantin acid
Dilantin®|Epanutin®|Phenytex®|phenytoin sodium
DILANTIN-125
DILANTIN-30
Dilantine
Dillantin
Dintoin
Dintoina
Diphantoin
Diphedal
Diphedan
Diphenat
Diphenin
Diphenine
Diphentoin
Diphentyn
Diphenylan
Diphenylan sodium
Diphenylhydantoin
Diphenylhydantoinate, sodium
Diphenylhydantoine [French]
Diphenylhydatanoin
Di-Phetine
Ditoinate
DPH
Ekko
Elepsindon
Enkelfel
Epamin
Epanutin
Epasmir 5
Epdantoin Simple
Epdantoine simple
Epelin
Epifenyl
Epihydan
Epilan
Epilan D
Epilan-D
Epilantin
Epinat
Epised
Eptal
Eptoin
Fenantoin
Fenidantoin s
Fenitoin
Fenitoina
Fenitoina [INN-Spanish]
|
Fentoin
Fenylepsin
Fenytoin Dak
Fenytoine
Gerot-epilan-D
Hidan
Hidantal
Hidantilo
Hidantina
Hidantina senosian
Hidantina vitoria
Hidantomin
Hindatal
Hydantal
Hydantin
Hydantoin
Hydantoinal
Hydantol
Ictalis simple
Idantoil
Idantoin
Iphenylhydantoin
Kessodanten
Labopal
Lehydan
Lepitoin
Lepsin
Mesantoin
Minetoin
Neos-Hidantoina
Neosidantoina
Novantoina
Novophenytoin
NSC-8722
Om hidantoina simple
Om-Hydantoine
Oxylan
Park davis brand OF phenytoin
Pfizer brand OF phenytoin
Phanantin
Phanatine
Phenatine
Phenatoine
Phenhydan
Phenhydanin
Phenitoin
Phentoin
PHENTYTOIN
PHENYTEK
PHENYTEX
Phenytoin
Phenytoin AWD
Phenytoin pfizer brand
Phenytoin phizer brand
Phenytoin sodium
Phenytoine
Phenytoine [INN-French]
Phenytoin-Gerot
Phenytoinum
Phenytoinum [INN-Latin]
Phizer brand OF phenytoin
Prompt Phenytoin Sodium
Ritmenal
Saceril
Sanepil
Silantin
Sinergina
SM-88 COMPONENT PHENYTOIN
Sodanthon
Sodantoin
Sodanton
Sodium diphenylhydantoinate
Solantin
Solantoin
Solantyl
Sylantoic
Tacosal
Thilophenyl
TOIN
Toin unicelles
Zentronal
Zentropil
|
|
Interventional clinical trials:
(show top 50)
(show all 238)
# |
Name |
Status |
NCT ID |
Phase |
Drugs |
1 |
Randomised, Double-blind, Placebo-controlled Trial of the Effect of the Combination of Imipramine and Pregabalin for the Treatment of Painful Polyneuropathy |
Unknown status |
NCT01047488 |
Phase 4 |
Imipramine;Pregabalin;Imipramine, pregabalin;Placebo |
2 |
Muscular Electrostimulation of the Sedated and Mechanically Ventilated Critically Ill Patient. Analysis of the Effect on Acquired Muscular Weakness and Its Clinical Consequences. |
Unknown status |
NCT02033057 |
Phase 4 |
|
3 |
Treatment With Gamunex 10% Intravenous Immunoglobulin (IVIg) for Patients With Demyelination and Diabetes Mellitus: A Blinded, Placebo-Controlled Crossover Pilot Study |
Unknown status |
NCT02372149 |
Phase 4 |
10% intravenous immunoglobulin (IVIg);0.9% sodium chloride |
4 |
Evaluation of the Impact of Subject and Staff Training on the Pregabalin vs. Placebo Difference in Subjects With Painful Diabetic Neuropathy (PDN) |
Unknown status |
NCT01770964 |
Phase 4 |
Pregabalin;placebo |
5 |
Treatment With Alpha-lipoic Acid Over 16 Weeks in Type 2 Diabetic Patients With Symptomatic Polyneuropathy Who Responded to Initial 4-week High-dose Loading |
Completed |
NCT02439879 |
Phase 4 |
Alpha lipoic acid |
6 |
Escitalopram as a Treatment for Pain in Polyneuropathy. A Double-Blind, Randomized, Placebo Controlled Trial. |
Completed |
NCT00162968 |
Phase 4 |
escitalopram |
7 |
Double-blind, Randomised, Placebo-controlled Trial of the Effect of Levetiracetam on Painful Polyneuropathy |
Completed |
NCT00286260 |
Phase 4 |
levetiracetam |
8 |
Patient Assisted Intervention for Neuropathy: Comparison of Treatment in Real Life Situations (PAIN-CONTRoLS) |
Completed |
NCT02260388 |
Phase 4 |
Nortriptyline;Duloxetine;Pregabalin;Mexiletine |
9 |
Asian Study on Cilostazol Effectivity in Neuropathies of Diabetes Mellitus Type 2-A Pilot Study in the Philippines |
Completed |
NCT01076478 |
Phase 4 |
Cilostazol |
10 |
Qutenza Versus Pregabalin in Subjects With Peripheral Neuropathic Pain: an Open-label, Randomized, Multicenter, Non-inferiority Efficacy and Tolerability Study |
Completed |
NCT01713426 |
Phase 4 |
Qutenza;Pregabalin |
11 |
Oxcarbazepine for the Treatment of Chronic Peripheral Neuropathic Pain: Predictors of Response - a Randomised, Double-blind, Placebo-controlled Clinical Trial |
Completed |
NCT01302275 |
Phase 4 |
Oxcarbazepine |
12 |
Randomized Double Blind Placebo Controlled Multicenter Study of the Efficacy and Safety of Repeated Administrations of Botulinum Toxin Type A (Botox) in the Treatment of Peripheral Neuropathic Pain |
Completed |
NCT01251211 |
Phase 4 |
botulinum toxin type A |
13 |
Randomized, Parallel Study of Subcutaneous Versus Intravenous Immunoglobulin in Treatment-naïve Patients With Chronic Inflammatory Demyelinating Polyneuropathy |
Recruiting |
NCT04589299 |
Phase 4 |
|
14 |
A Phase 4 Safety Study Assessing the Adverse Events Occurring Within One Day of TEGSEDI Administration in Patients With Polyneuropathy of Hereditary Transthyretin-mediated Amyloidosis (hATTR-PN) |
Recruiting |
NCT04306510 |
Phase 4 |
|
15 |
The Effect of Tafamidis on Transthyretin Stabilization, Safety, Tolerability and Efficacy in Transthyretin Amyloid Polyneuropathy Patients |
Recruiting |
NCT04963985 |
Phase 4 |
Tafamidis Pill |
16 |
Randomized Study of Two Dose Levels of Privigen in Pediatric CIDP |
Recruiting |
NCT03684018 |
Phase 4 |
|
17 |
A SINGLE ARM, MULTICENTER, OPEN-LABEL STUDY TO EVALUATE THE EFFICACY, SAFETY, TOLERABILITY, AND PHARMACODYNAMICS OF ORALLY ADMINISTERED TAFAMIDIS MEGLUMINE IN TRANSTHYRETIN AMYLOID POLYNEUROPATHY PARTICIPANTS IN CHINA |
Active, not recruiting |
NCT04828993 |
Phase 4 |
tafamidis meglumine |
18 |
A Double-blind, Placebo-controlled, Cross-over Study of Ranolazine in Patients With Coronary Artery Disease for the Treatment of Painful Polyneuropathy |
Terminated |
NCT00832572 |
Phase 4 |
Ranolazine;Placebo |
19 |
Efficacy, Safety, Tolerability and Pharmacokinetics of Concomitant Administration of Tramadol With Duloxetine or Pregabalin: a Randomized Controlled Flexible-dose Study in Patients With Neuropathic Pain |
Withdrawn |
NCT01116531 |
Phase 4 |
Tramadol;Duloxetine;Pregabalin |
20 |
Effects of Benfotiamine on Intraepidermal Nerve Fiber Density (IENFD)and Diabetic Neuropathy in Subjects With Sensorimotor Diabetic Polyneuropathy: a Double-blind, Randomized, Placebo-controlled Parallel Group Pilot Study Over 12 Months. |
Unknown status |
NCT01868191 |
Phase 3 |
Benfotiamine;Placebo for benfotiamine |
21 |
Prospective, Open-Label, Phase IIIb Study Evaluating the Safety, Tolerability and Efficacy of Panzyga® in Patients With Chronic Inflammatory Demyelinating Polyneuropathy Administered at Standard and High Infusion Rates |
Unknown status |
NCT03166527 |
Phase 3 |
Immune Globulin 10% Intravenous Solution |
22 |
Randomized, Double-Blind, Placebo-Controlled, Parallel Group, Multicenter Study to Evaluate the Efficacy and Safety of Thioctacid Oral Tablet 600mg Once Daily in Chinese Diabetic Patients With Distal Symmetric Polyneuropathy |
Unknown status |
NCT01224353 |
Phase 2, Phase 3 |
lipoic acid |
23 |
Neuromuscular Electrical Stimulation for Intensive Care Unit-acquired Weakness |
Unknown status |
NCT02706587 |
Phase 3 |
|
24 |
Pilot Randomized, Controlled Trial of Testosterone Therapy in Chronic Critically Ill Patients and Its Potential Effects on Weaning From Mechanical Ventilation and Intensive Care Unit-acquired Weakness |
Unknown status |
NCT03038919 |
Phase 2, Phase 3 |
Testosterone cypionate |
25 |
APOLLO: A Phase 3 Multicenter, Multinational, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Patisiran (ALN-TTR02) in Transthyretin (TTR)-Mediated Polyneuropathy (Familial Amyloidotic Polyneuropathy-FAP) |
Completed |
NCT01960348 |
Phase 3 |
patisiran (ALN-TTR02);Sterile Normal Saline (0.9% NaCl) |
26 |
Multicenter, Double-blind, Placebo-controlled Randomized Clinical Trial of Efficacy and Safety of the Drug Cytoflavin®, Administered Intravenously Followed by Oral Intake, in Patients With Diabetic Polyneuropathy |
Completed |
NCT04649203 |
Phase 3 |
Cytoflavin (Inosine + Nicotinamide + Riboflavin + Succinic Acid);Placebo |
27 |
Multicenter, Open-label Extension Study to Investigate the Long-term Safety and Efficacy of IgPro20 in Maintenance Treatment of Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) in Subjects Completing Study IgPro20_3003 |
Completed |
NCT02027701 |
Phase 3 |
|
28 |
Safety and Efficacy of Orally Administered Fx-1006A in Patients With Familial Amyloid Polyneuropathy (FAP): A Randomized, Double-blind, Placebo-controlled Study |
Completed |
NCT00409175 |
Phase 2, Phase 3 |
Fx-1006A;Placebo |
29 |
An Open-Label Extension Of Study Fx-005 Evaluating Long-Term Safety And Clinical Outcomes Of Fx-1006A In Patients With Transthyretin Amyloid Polyneuropathy |
Completed |
NCT00791492 |
Phase 2, Phase 3 |
Fx-1006A |
30 |
A Multi-centre, Double-blind, Placebo-controlled, Randomised, Parallel Group Clinical Trial to Evaluate Efficacy and Safety of Actovegin® in Diabetic Type 2 Patients With Symptomatic Diabetic Peripheral Polyneuropathy |
Completed |
NCT00483730 |
Phase 3 |
Deproteinised hemoderivative of calf blood (Actovegin) |
31 |
A Multicenter, Open-Label, Extension Study to Evaluate the Long-term Safety and Efficacy of Patisiran in Patients With Familial Amyloidotic Polyneuropathy Who Have Completed a Prior Patisiran Clinical Study |
Completed |
NCT02510261 |
Phase 3 |
Patisiran (ALN-TTR02) |
32 |
Phase III Randomized, Double-Blind, Placebo-Controlled Study of Intravenous Immune Globulin for Chronic Inflammatory Demyelinating Polyneuropathy |
Completed |
NCT00004772 |
Phase 3 |
Immune globulin |
33 |
Safety and Efficacy of AS-3201 in the Treatment of Diabetic Sensorimotor Polyneuropathy |
Completed |
NCT00101426 |
Phase 3 |
ranirestat, (AS-3201) |
34 |
Assessment of Efficacy and Safety of Thioctic Acid in the Oral Treatment of Diabetic Polyneuropathy (Stage 1 or 2) NATHAN1 A Randomized, Placebo-controlled, Double-blind Multi-centre Trial With 2 Parallel Groups |
Completed |
NCT00977483 |
Phase 3 |
Thioctic Acid;Placebo |
35 |
Double-blind Randomized Trial of Rituximab Versus Placebo in Polyneuropathy Associated With Anti-MAG IgM Monoclonal Gammopathy |
Completed |
NCT00259974 |
Phase 3 |
Rituximab |
36 |
Multicenter, Randomized, Double-blind, Placebo-controlled, Study to Evaluate the Efficacy and Safety of IGIV-Chromatography (IGIV-C), 10% Treatment in Subjects With Chronic Inflammatory Demyelinating Polyneuropathy |
Completed |
NCT00220740 |
Phase 3 |
Immune Globulin IV (Human), 10% Caprylate/Chromatography Purified;Albumin (Human) 25%, United States Pharmacopeia (USP) |
37 |
A Randomized, Double-Blind, Controlled Dose Finding Study of NGX-4010 for the Treatment of Painful HIV-Associated Distal Symmetrical Polyneuropathy |
Completed |
NCT00064623 |
Phase 3 |
Capsaicin Dermal Patch |
38 |
Phase III Randomized, Double-Blind, Placebo-Controlled Study of 3,4-Diaminopyridine for Demyelinating Polyneuropathy |
Completed |
NCT00004939 |
Phase 3 |
,4-diaminopyridine |
39 |
A 2-year, Randomized, Double-blind, Placebo-controlled, Multi-center, Phase II-III Study to Evaluate the Efficacy and Safety of Oral Ranirestat (40 and 80 mg) in Mild to Moderate Diabetic Sensorimotor Polyneuropathy |
Completed |
NCT00927914 |
Phase 2, Phase 3 |
Ranirestat;Placebo |
40 |
Neuropathic Pain Treatment Using F0434 vs. Gabapentin in Patients With Chronic Distal Diabetic Polyneuropathy: A Randomized, Controlled, Double-blind Study |
Completed |
NCT01263132 |
Phase 3 |
F0434;Gabapentin |
41 |
Randomized, Multicenter, Double-blind, Placebo-controlled, Parallel-group Phase III Study to Investigate the Efficacy, Safety, and Tolerability of 2 Different Doses of IgPro20 (Subcutaneous Immunoglobulin) for the Treatment of Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) - the PATH Study |
Completed |
NCT01545076 |
Phase 3 |
|
42 |
An Open-Label Extension Study to Assess the Long-Term Safety and Efficacy of ISIS 420915 in Patients With Familial Amyloid Polyneuropathy (FAP) |
Completed |
NCT02175004 |
Phase 3 |
IONIS-TTR Rx |
43 |
The Effect On Transthyretin Stabilization, Safety, Tolerablity, Efficacy And Pharmacokinetics Of Orally Administered Tafamidis In Transthyretin Amyloid Polyneuropathy Patients With V30m Or Non-v30m Transthyretin: A Phase Iii, Open-label Study |
Completed |
NCT01435655 |
Phase 3 |
tafamidis |
44 |
Multicentre Randomized Open-label Trial to Compare Efficacy and Tolerance of Corticosteroids and IVIg in Patients With Chronic Inflammatory Demyelinating Polyneuropathy on a One Year Follow up |
Completed |
NCT01349270 |
Phase 3 |
Immunoglobulin perfusion;Prednisone |
45 |
NPB-01(Intravenous Immunoglobulin) Maintenance Therapy for Patients With Chronic Inflammatory Demyelinating Polyneuropathy. |
Completed |
NCT01824251 |
Phase 3 |
NPB-01 |
46 |
A Phase 2/3 Randomized, Double-Blind, Placebo-Controlled Study to Assess the Efficacy and Safety of ISIS 420915 in Patients With Familial Amyloid Polyneuropathy (NEURO-TTR Study) |
Completed |
NCT01737398 |
Phase 2, Phase 3 |
Inotersen;Placebo |
47 |
A Single-arm Study to Demonstrate the Efficacy and Safety of Privigen in the Treatment of Subjects With Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) |
Completed |
NCT01184846 |
Phase 3 |
|
48 |
Muscarinic Receptor Antagonists as a Therapy for Diabetic Neuropathy |
Completed |
NCT03050827 |
Phase 3 |
3% oxybutynin;Placebo |
49 |
Assessment of Efficacy and Safety of Thioctic Acid in the Oral Treatment of Symptomatic Diabetic Neuropathy (SYDNEY 2) Randomised, Double-blind,Placebo-controlled Multicentre Trial With 4 Parallel Groups |
Completed |
NCT00328601 |
Phase 3 |
Thioctic Acid |
50 |
The Effect of Diflunisal on Familial Amyloidosis |
Completed |
NCT00294671 |
Phase 2, Phase 3 |
diflunisal |
Cochrane evidence based reviews: polyneuropathies
|